US Stock MarketDetailed Quotes
TRVI Trevi Therapeutics
- 2.780
- +0.240+9.45%
Close Apr 26 16:00 ET
- 2.780
- 0.0000.00%
Post 16:20 ET
191.71MMarket Cap-9586P/E (TTM)
2.800High2.500Low56.18KVolume2.500Open2.540Pre Close152.03KTurnover0.14%Turnover RatioLossP/E (Static)68.96MShares4.00052wk High2.32P/B109.07MFloat Cap0.97052wk Low--Dividend TTM39.23MShs Float10.620Historical High--Div YieldTTM11.81%Amplitude0.460Historical Low2.705Avg Price1Lot Size
Trevi Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -12.55%-31.71M | -0.44%-6.36M | 15.12%-7.28M | -59.89%-9.88M | -15.58%-8.2M | 2.66%-28.18M | -1.64%-6.33M | -18.44%-8.58M | 21.80%-6.18M | 6.41%-7.09M |
| Net income from continuing operations | 0.30%-29.07M | -42.07%-7.82M | 6.87%-7.7M | 11.26%-7.15M | 12.66%-6.4M | 14.11%-29.15M | 35.39%-5.51M | -13.94%-8.27M | 17.79%-8.05M | 12.45%-7.33M |
| Operating gains losses | -93.20%10K | --0 | --0 | --0 | -9.09%10K | 279.27%147K | --0 | --0 | 440.00%136K | 83.33%11K |
| Depreciation and amortization | 186.05%123K | 133.33%35K | 288.89%35K | 325.00%34K | 72.73%19K | -14.00%43K | 25.00%15K | -30.77%9K | -33.33%8K | -15.38%11K |
| Other non cash items | 7.12%557K | 11,700.00%118K | -23.23%119K | 13.81%239K | -47.40%81K | -46.61%520K | -99.36%1K | 2.65%155K | -59.69%210K | 6.21%154K |
| Change In working capital | -212.51%-3.85M | 194.12%736K | 124.44%207K | -377.19%-2.98M | -168.20%-1.81M | -181.58%-1.23M | -147.83%-782K | -21.87%-847K | 63.22%1.07M | -659.55%-676K |
| -Change in prepaid assets | -374.21%-2.85M | 486.36%85K | -242.04%-446K | -25.89%-1.65M | -299.05%-836K | -275.73%-601K | -104.74%-22K | -33.19%314K | -3.30%-1.31M | -38.14%420K |
| -Change in payables and accrued expense | -58.25%-997K | 185.66%651K | 156.24%653K | -155.47%-1.32M | 10.86%-977K | -153.98%-630K | -164.90%-760K | 0.34%-1.16M | 23.74%2.39M | -42.71%-1.1M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -12.55%-31.71M | -0.44%-6.36M | 15.12%-7.28M | -59.89%-9.88M | -15.58%-8.2M | 2.66%-28.18M | -1.64%-6.33M | -18.44%-8.58M | 21.80%-6.18M | 6.41%-7.09M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 155.35%59.43M | 126.59%12.85M | 470.76%17.98M | 136.22%19.64M | 8.96M | -107.37M | -48.31M | -4.85M | -54.22M | 0 |
| Net PPE purchase and sale | 13.84%-137K | 81.03%-22K | 58.14%-18K | ---40K | ---57K | ---159K | ---116K | ---43K | --0 | --0 |
| Net investment purchase and sale | 155.56%59.57M | 126.70%12.87M | 474.45%18M | 136.30%19.68M | --9.02M | ---107.21M | ---48.19M | ---4.81M | ---54.22M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 155.35%59.43M | 126.59%12.85M | 470.76%17.98M | 136.22%19.64M | --8.96M | ---107.37M | ---48.31M | ---4.85M | ---54.22M | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -107.11%-7.91M | -108.28%-54K | -97.27%1.51M | -113.69%-7.66M | -172.48%-1.7M | 435.77%111.31M | -95.26%652K | 41,170.15%55.3M | 1,933.35%55.98M | -115.07%-625K |
| Net issuance payments of debt | -62.94%-9.5M | 98.17%-32K | 98.23%-31K | -339.49%-7.69M | -200.17%-1.75M | ---5.83M | ---1.75M | ---1.75M | ---1.75M | ---583K |
| Net common stock issuance | -98.38%1.71M | --0 | -96.66%1.71M | ---- | ---- | 397.62%105.41M | -82.45%2.4M | 9,503.00%51.18M | ---- | ---- |
| Proceeds from stock option exercised by employees | -98.81%142K | 9.09%36K | -99.95%3K | -99.31%41K | 3,000.00%62K | 28,416.67%11.98M | 32.00%33K | --6.03M | 34,682.35%5.91M | --2K |
| Net other financing activities | -4.45%-258K | -87.10%-58K | -6.83%-172K | -18.18%-13K | 65.91%-15K | 45.11%-247K | -181.58%-31K | 59.65%-161K | 81.03%-11K | -41.94%-44K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -107.11%-7.91M | -108.28%-54K | -97.27%1.51M | -113.69%-7.66M | -172.48%-1.7M | 435.77%111.31M | -95.26%652K | 41,170.15%55.3M | 1,933.35%55.98M | -115.07%-625K |
| Net cash flow | ||||||||||
| Beginning cash position | -65.82%12.59M | -61.00%25.97M | -44.32%13.75M | -59.98%11.65M | -65.82%12.59M | -18.16%36.83M | 127.08%66.57M | -32.19%24.7M | -29.97%29.11M | -18.16%36.83M |
| Current changes in cash | 181.71%19.81M | 111.91%6.43M | -70.84%12.21M | 147.59%2.1M | 87.85%-938K | -196.67%-24.24M | -818.65%-53.99M | 689.22%41.88M | 14.19%-4.42M | -124.92%-7.72M |
| End cash Position | 157.34%32.4M | 157.34%32.4M | -61.00%25.97M | -44.32%13.75M | -59.98%11.65M | -65.82%12.59M | -65.82%12.59M | 127.08%66.57M | -32.19%24.7M | -29.97%29.11M |
| Free cash flow | -12.40%-31.85M | 1.02%-6.38M | 15.34%-7.3M | -60.54%-9.92M | -16.38%-8.25M | 2.11%-28.33M | -3.50%-6.45M | -19.03%-8.62M | 21.80%-6.18M | 6.41%-7.09M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg